An article by Julia Wcislo is one of the ten outstanding articles that have been shortlisted for the 2020 Max Perutz Science Writing Award, the MRC’s annual writing competition.
Wellcome Centre for Anti-Infectives Research (CAIR)
Scientists at the Wellcome Centre for Anti-Infectives Research (WCAIR) at the University of Dundee have been awarded £4.9million in follow-on funding from the Wellcome Trust, boosting their efforts to understand more about potential drugs that could be used to treat neglected tropical diseases (NTDs) and other parasitic diseases.
During lockdown, the School of Life Sciences at the University of Dundee was not closed. Work continued albeit on a much smaller scale than usual, with the majority of the ongoing research focussed on coronavirus. Our support staff were absolutely critical in keeping the research complex functioning to allow this important work to happen. As we have entered phase 2 of the Scottish Government’s route map out of lockdown, we look back over the past few months and the challenges that our community in the School encountered and had to overcome.
A raft of family-friendly activities highlighting the ‘superhero powers’ of microbes have been lined up by University of Dundee scientists to keep children engaged in science during lockdown.
Researchers from the School of Life Sciences are taking over Dundee Science Centre’s Home Learning Programme for five days as of Monday 8 June 2020, supporting parents and carers with home schooling.
The team will be sharing the amazing world of life at the far end of the microscope, looking at the monumental impact of microscopic microbes.
Back in October 2013 Medicines for Malaria Venture (MMV) selected a compound designed and developed at the Drug Discovery Unit (DDU), University of Dundee to enter preclinical development. In June 2015, the discovery, properties and mode of action of the compound DDD107498 were published in the journal Nature.
The University of Dundee is working with partners around the world as part of an expanding effort to rapidly repurpose existing drugs against Covid-19.
An international research network established by Scripps Research centres around ReFRAME, the world’s leading collection of drugs known to be safe in humans.
The network of collaborating scientific laboratories is aiming to leverage ReFRAME to find antiviral compounds against the novel coronavirus.